Rhythm Pharmaceuticals Inc Earnings

Rhythm Pharmaceuticals Inc’s revenue jumped 25.94% since last year same period to $32.7Mn in the Q1 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated -21.82% fall in its revenue since last 3-months.

Rhythm Pharmaceuticals Inc’s net profit jumped 64.99% since last year same period to $-49.5Mn in the Q1 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated -14.34% fall in its net profits since last 3-months.

Rhythm Pharmaceuticals Inc’s net profit margin jumped 72.2% since last year same period to -151.35% in the Q1 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated -46.24% fall in its net profit margins since last 3-months.

Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.64 - a 2.31% jump from last quarter’s estimates.

Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.64.

Rhythm Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Rhythm Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.